April 28, 2026
The U.S. Supreme Court in Washington.
Rahmat Gul/AP

Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims

Roundup maker Monsanto is backed by Trump administration, a legal position that's at odds with some MAHA allies who want to rein in pesticides.

By Associated Press

A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts

STAT reporters discuss how one biotech that almost shut down got acquired by Eli Lilly and how drugmakers are trying to drive more scripts.

By Allison DeAngelis, Elaine Chen, and Adam Feuerstein

STAT+ | Astellas retries XLMTM gene therapy after deaths

In today's biotech news: Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more

By Meghana Keshavan
Pancreatic red cancer cells.
NIH

STAT+ | Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy

The drugmaker hopes that its treatment can outperform a pill from Revolution Medicines that is being closely tracked.

By Adam Feuerstein
More around STAT

In case you missed it

  • Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America, CBS News

  • Scientists search the microbiome for clues to the rise in colorectal cancers, NPR
  • Revolution Medicines could soon launch a pancreatic-cancer drug. Its stock may already be beyond what established pharmaceutical firms can pay, Wall Street Journal
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.
Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.
Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser